These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21078706)

  • 21. Coincident posttraumatic stress disorder and depression predict alcohol abuse during and after deployment among Army National Guard soldiers.
    Marshall BD; Prescott MR; Liberzon I; Tamburrino MB; Calabrese JR; Galea S
    Drug Alcohol Depend; 2012 Aug; 124(3):193-9. PubMed ID: 22342428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttraumatic stress symptoms across the deployment cycle: A latent transition analysis.
    Boasso AM; Steenkamp MM; Larson JL; Litz BT
    J Psychiatr Res; 2016 Dec; 83():54-60. PubMed ID: 27566139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Predeployment Heart Rate Variability With Risk of Postdeployment Posttraumatic Stress Disorder in Active-Duty Marines.
    Minassian A; Maihofer AX; Baker DG; Nievergelt CM; Geyer MA; Risbrough VB;
    JAMA Psychiatry; 2015 Oct; 72(10):979-86. PubMed ID: 26353072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are personnel with a past history of mental disorders disproportionately vulnerable to the effects of deployment-related trauma? A cross-sectional study of Canadian military personnel.
    Beliveau PJH; Sampasa-Kanyinga H; Colman I; Zamorski MA
    BMC Psychiatry; 2019 May; 19(1):156. PubMed ID: 31117963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emotional reactivity to a single inhalation of 35% carbon dioxide and its association with later symptoms of posttraumatic stress disorder and anxiety in soldiers deployed to Iraq.
    Telch MJ; Rosenfield D; Lee HJ; Pai A
    Arch Gen Psychiatry; 2012 Nov; 69(11):1161-8. PubMed ID: 23117637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine production as a putative biological mechanism underlying stress sensitization in high combat exposed soldiers.
    Smid GE; van Zuiden M; Geuze E; Kavelaars A; Heijnen CJ; Vermetten E
    Psychoneuroendocrinology; 2015 Jan; 51():534-46. PubMed ID: 25106657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual variation in plasma oxytocin and vasopressin levels in relation to the development of combat-related PTSD in a large military cohort.
    Reijnen A; Geuze E; Vermetten E
    J Psychiatr Res; 2017 Nov; 94():88-95. PubMed ID: 28689067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder.
    Yehuda R; Flory JD; Bierer LM; Henn-Haase C; Lehrner A; Desarnaud F; Makotkine I; Daskalakis NP; Marmar CR; Meaney MJ
    Biol Psychiatry; 2015 Feb; 77(4):356-64. PubMed ID: 24661442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte glucocorticoid receptor expression level and hormone-binding properties differ between war trauma-exposed men with and without PTSD.
    Matić G; Milutinović DV; Nestorov J; Elaković I; Jovanović SM; Perišić T; Dunđerski J; Damjanović S; Knežević G; Špirić Ž; Vermetten E; Savić D
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():238-45. PubMed ID: 23333536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of time since deployment, combat intensity, and posttraumatic stress symptoms with neuropsychological outcomes following Iraq war deployment.
    Marx BP; Brailey K; Proctor SP; Macdonald HZ; Graefe AC; Amoroso P; Heeren T; Vasterling JJ
    Arch Gen Psychiatry; 2009 Sep; 66(9):996-1004. PubMed ID: 19736356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder.
    Yehuda R; Golier JA; Yang RK; Tischler L
    Biol Psychiatry; 2004 Jun; 55(11):1110-6. PubMed ID: 15158431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of altered intracellular endocrine-immune interplay in Bosnian war refugees suffering from PTSD.
    Pitts KP; Joksimovic L; Steudte-Schmiedgen S; Rohleder N; Wolf JM
    Biol Psychol; 2016 Jul; 118():1-7. PubMed ID: 27086273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment.
    Olivera A; Lejbman N; Jeromin A; French LM; Kim HS; Cashion A; Mysliwiec V; Diaz-Arrastia R; Gill J
    JAMA Neurol; 2015 Oct; 72(10):1109-16. PubMed ID: 26237304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.
    Eraly SA; Nievergelt CM; Maihofer AX; Barkauskas DA; Biswas N; Agorastos A; O'Connor DT; Baker DG;
    JAMA Psychiatry; 2014 Apr; 71(4):423-31. PubMed ID: 24576974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SKA2 Methylation is Involved in Cortisol Stress Reactivity and Predicts the Development of Post-Traumatic Stress Disorder (PTSD) After Military Deployment.
    Boks MP; Rutten BP; Geuze E; Houtepen LC; Vermetten E; Kaminsky Z; Vinkers CH
    Neuropsychopharmacology; 2016 Apr; 41(5):1350-6. PubMed ID: 26361058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.
    Su TP; Zhang L; Chung MY; Chen YS; Bi YM; Chou YH; Barker JL; Barrett JE; Maric D; Li XX; Li H; Webster MJ; Benedek D; Carlton JR; Ursano R
    J Psychiatr Res; 2009 Sep; 43(13):1078-85. PubMed ID: 19380152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of pre-deployment neurocognitive functioning on post-deployment PTSD symptom outcomes among Iraq-deployed Army soldiers.
    Marx BP; Doron-Lamarca S; Proctor SP; Vasterling JJ
    J Int Neuropsychol Soc; 2009 Nov; 15(6):840-52. PubMed ID: 19891817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying clusters of health symptoms in deployed military personnel and their relationship with probable PTSD.
    Graham K; Dipnall J; Van Hooff M; Lawrence-Wood E; Searle A; Ao AM
    J Psychosom Res; 2019 Dec; 127():109838. PubMed ID: 31698167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of genetic vulnerability and military deployment on the development of post-traumatic stress disorder and depressive symptoms.
    Schür RR; Schijven D; Boks MP; Rutten BPF; Stein MB; Veldink JH; Joëls M; Geuze E; Vermetten E; Luykx JJ; Vinkers CH
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):405-415. PubMed ID: 30773389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships among predeployment risk factors, warzone-threat appraisal, and postdeployment PTSD symptoms.
    Franz MR; Wolf EJ; MacDonald HZ; Marx BP; Proctor SP; Vasterling JJ
    J Trauma Stress; 2013 Aug; 26(4):498-506. PubMed ID: 23893499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.